Joe Mullings frames governance as the protective membrane around external innovation, shielding elite teams from bureaucracy and politics that can erode their advantage.
Joe Mullings explains how the wrong operator can collapse a build-to-buy partnership—and why acquisition creates the greatest risk of losing the team.
Joe Mullings shows how the first leader in a stealth innovation effort becomes its strongest validation signal, attracting elite talent and market confidence.
Joe Mullings explores why large organizations can repel breakthrough builders, making external innovation a structural answer to the constraints of corporate scale.
Joe Mullings argues MedTech’s innovation bottleneck isn’t capital but rare full-arc talent—and that build-to-buy ultimately succeeds or fails on talent architecture.